Search Results - "SIRTORI, Cesare"
-
1
The pharmacology of statins
Published in Pharmacological research (01-10-2014)“…Statins, inhibitors of the hydroxymethylglutaryl-CoA (HMG-CoA) reductase enzyme, are molecules of fungal origin. By inhibiting a key step in the sterol…”
Get full text
Journal Article -
2
PPAR Agonists and Metabolic Syndrome: An Established Role?
Published in International journal of molecular sciences (14-04-2018)“…Therapeutic approaches to metabolic syndrome (MetS) are numerous and may target lipoproteins, blood pressure or anthropometric indices. Peroxisome…”
Get full text
Journal Article -
3
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications
Published in Cardiovascular research (18-01-2023)“…Treatment with statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, has proven beneficial preventive effects on cardiovascular events…”
Get full text
Journal Article -
4
Proprotein Convertase Subtilisin/Kexin Type 9: A View beyond the Canonical Cholesterol-Lowering Impact
Published in The American journal of pathology (01-08-2021)Get full text
Journal Article -
5
Carotid IMT and atherosclerosis: “Calling things by name”
Published in Atherosclerosis (01-01-2021)Get full text
Journal Article -
6
PCSK9 inhibition and inflammation: A narrative review
Published in Atherosclerosis (01-09-2019)“…Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality despite excellent pharmacological and revascularization…”
Get full text
Journal Article -
7
Challenges and Opportunities for Mycoprotein-Based Food Products
Published in The American journal of clinical nutrition (01-07-2023)Get full text
Journal Article -
8
Clinical approach to the inflammatory etiology of cardiovascular diseases
Published in Pharmacological research (01-09-2020)“…[Display omitted] Inflammation is an obligatory marker of arterial disease, both stemming from the inflammatory activity of cholesterol itself and from…”
Get full text
Journal Article -
9
The Role of High-Density Lipoprotein Cholesterol in 2022
Published in Current atherosclerosis reports (01-05-2022)“…Purpose of the Review High-density lipoproteins (HDL) are responsible for the transport in plasma of a large fraction of circulating lipids, in part from…”
Get full text
Journal Article -
10
Bempedoic Acid: for Whom and When
Published in Current atherosclerosis reports (01-10-2022)“…Purpose of Review The aim of creating an orally active non-statin cholesterol-lowering drug was achieved with bempedoic acid, a small linear molecule providing…”
Get full text
Journal Article -
11
Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia
Published in Pharmacological research (01-03-2020)“…[Display omitted] Among the determinants of atherosclerotic cardiovascular disease (ASCVD), genetic and experimental evidence has provided data on a major role…”
Get full text
Journal Article -
12
Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches
Published in European journal of clinical investigation (01-07-2021)“…Background A consensus of experts has proposed to replace the term nonalcoholic fatty liver disease (NAFLD), whose global prevalence is 25%, with metabolic…”
Get full text
Journal Article -
13
Unravelling the health effects of fasting: a long road from obesity treatment to healthy life span increase and improved cognition
Published in Annals of medicine (Helsinki) (03-07-2020)“…In recent years a revival of interest has emerged in the health benefits of intermittent fasting and long-term fasting, as well as of other related nutritional…”
Get full text
Journal Article -
14
Lipoprotein(a): Knowns, unknowns and uncertainties
Published in Pharmacological research (01-11-2021)“…Over the last 10 years, there have been advances on several aspects of lipoprotein(a) which are reviewed in the present article. Since the standard…”
Get full text
Journal Article -
15
Metformin: From diabetes to cancer to prolongation of life
Published in Pharmacological research (01-10-2024)“…The metformin molecule dates back to over a century, but its clinical use started in the ‘50s. Since then, its use in diabetics has grown constantly, with over…”
Get full text
Journal Article -
16
PCSK9 Inhibition and Risk of Diabetes: Should We Worry?
Published in Current atherosclerosis reports (01-12-2022)“…Purpose of Review Since the clinical benefit of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors occurs in a setting of reducing low-density…”
Get full text
Journal Article -
17
Lipid Lowering Drugs: Present Status and Future Developments
Published in Current atherosclerosis reports (10-03-2021)“…Purpose of review Based on the recent data of the DA VINCI study, it is clear that, besides utilization of statins, there is a need to increase non-statin…”
Get full text
Journal Article -
18
Pharmacological rationale for the very early treatment of acute coronary syndrome with monoclonal antibodies anti-PCSK9
Published in Pharmacological research (01-10-2022)“…Immediate and aggressive lipid lowering therapies after acute coronary syndromes (ACS) and percutaneous coronary interventions (PCI) are supported by the…”
Get full text
Journal Article -
19
Present therapeutic role of cholesteryl ester transfer protein inhibitors
Published in Pharmacological research (01-02-2018)“…[Display omitted] Therapeutic interventions aimed at increasing high-density lipoprotein (HDL) levels in order to reduce the residual cardiovascular (CV) risk…”
Get full text
Journal Article -
20